A Comprehensive research study conducted by KD Market Research for Amniotic Membrane Market span of 7 years i.e. from 2017 and 2023 .Opportunity Analysis and this report offers extensive and highly detailed historical, current and future market trends in Amniotic Membrane Market includes market size, growth drivers, barriers, opportunities, trends and other information which helps to find new opportunities in this market for the growth of the business through new technologies and developments. Amniotic Membrane Market was held at USD XXX Million in 2017 and is expected to garner USD XXX Million by the end of 2023
Request for sample@ https://www.kdmarketresearch.com/sample/3463
The global amniotic membrane market size was valued at USD 2.26 billion in 2017 and is estimated to register a CAGR of 12.6% during the forecast period. The amnion is the innermost layer of the placenta and is used for wound healing mainly due to its bacteriostatic and pain reduction properties. Rising awareness in the recent past has led to a surge in the number of transplants leading to increasing demand for these tissue-based products. It has also led to a rise in the number of donations thus, fueling market growth.
The major factors that drive the growth of the amniotic membrane market is the rise geriatric population coupled with the increase in amniotic membrane based transplantation globally. However, dearth of skilled professionals and high cost of the surgeries involving amniotic membrane restrain the growth of the global amniotic membrane market. Moreover, the increase in awareness regarding the potential benefits of amniotic membrane among the patients as well as the healthcare professionals offers lucrative opportunities that boost the market.
The global amniotic membrane market is segmented based on product, application, end user, and region. Based on product, the market is bifurcated into cryopreserved amniotic membrane and lyophilization amniotic membrane. Based on application, it is divided into surgical wounds, ophthalmology, and others. Based on end user, itis classified into hospitals, ambulatory surgical centers, specialized clinics, and research centers & laboratory
Amniotic membranes are used in two categories, as a surgical graft or as a biological bandage for the treatment and management of wounds. The product usage facilitates re-epithelization acting as a scaffold when used as a graft. Its anti-inflammatory and anti-scarring properties are especially vital in case of burn injuries reducing intensified inflammation and discomfort.
Based on application, the market is segmented into surgical wounds, ophthalmology, and others. These products are most often used in ophthalmic surgeries to initiate faster recovery while reducing inflammation. These membranes are also used in reconstructive surgeries to reduce scarring and promote healing. According to estimates from American Society of Plastic Surgeons, over 17.5 million surgical cosmetic procedures were performed in U.S. in 2017. These facts are indicative of the rising number of individuals undergoing surgery to enhance their aesthetic appeal.
Thus, high product demand in cosmetic surgeries is boosting the market growth. These products are also used in reconstructive procedures, which is also propelling their demand. Usage of amniotic membranes for burn injury treatments enables rapid wound healing and epithelialization. It is also proven to reduce pain and facilitate easy movement of the affected area. Since the usage of this method proves to be cheaper than xenografts and allografts, it is increasingly being used across the globe, which is accelerating the segment growth.
End Use Insights
On the basis of end use, the market is segmented into hospitals, Ambulatory Surgical Centers (ASCs), specialty clinics, and research and academic institutes. Hospitals are the primary care settings facilitating easy treatment for a wide range of diseases. These end use settings held the largest market share owing to frequent visits by patients and its ability to cater to a varied range of surgical interventions.
Rising use of amniotic membranes in ASCs is driving the segment growth. The use of these products is easy and effective and also facilitates wound recovery without frequent visits to hospitals or clinics. Thus, the ASC settings are also likely to witness rapid growth over the next few years.
Specialty clinics that are taken into consideration in the study are burn centers, plastic surgery clinics, dermatology clinics, and others. As most of these require methods to prevent infections and promote effective wound healing, the use of amniotic membranes is frequently seen in these settings facilitating market growth.
Research and academic institutes segment also holds a significant share in the amniotic membrane market owing to increasing R&D investments by major market players and hospitals to understand the possible product applications. The amniotic membrane provides a substrate for stem cells and can be used in various applications, propelling increasing research on the subject.
Enzyme Insights
Amniotic Membrane Market Share
The market constitutes a large number of global as well as local companies. These include Alliqua BioMedical, Inc.; Amnio Technology, LLC; Applied Biologics LLC; Human Regenerative Technologies, LLC; Derma Sciences; Katena Products, Inc.; MiMedx Group, Inc.; Skye Biologics, Inc.; Amniox Medical, Inc.; and Organogensis, Inc.
Majority of these companies have a well-established portfolio and have strong collaborations with tissue banks and hospitals to ensure placental donations. Almost all of the key market players are accredited by the American Association for Tissue Banks (AATB) to provide quality and sterile products. These factors thus are anticipated to aid in the growth of the market during the forecast period.
Companies are also involved in developing and marketing of membranes that are solely focused on specific areas of application. For instance, AmnioFix developed by MiMedx Group Inc. is a dehydrated product that is used particularly for surgical incisions, as it acts as a barrier membrane and reduces scar tissue formations.
Segments in this Report
By Product
Cryopreserved Amniotic Membrane
Lyophilization Amniotic Membrane
By Application
Surgical Wounds
Ophthalmology
Others
By End User
Hospitals Ambulatory Surgical Centers
Specialized Clinics
Research Centers & Laboratory
By Region
North America
U.S.
Canada
Mexico
Europe
Asia-Pacific
LAMEA
Browse full report with toc@ https://www.kdmarketresearch.com/report/amniotic-membrane-market-amr
Table of content
CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Benefits For Stakeholders
1.3. Key Market Segments
1.4. Research Methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market Definition And Scope
3.2. Key Findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.2.3. Top Winning Strategies, By Year, 2014-2017*
3.2.4. Top Winning Strategies, By Development, 2014-2017* (%)
3.2.5. Top Winning Strategies, By Company, 2014-2017*
3.3. Porters Five Forces Analysis
3.4. Top Player Positioning
3.5. Market Dynamics
3.5.1. Drivers
3.5.1.1. Growth in geriatric population
3.5.1.2. Increasing technological advancements and rising amniotic membrane transplantations
3.5.1.3. Increased awareness to reduce healthcare costs
3.5.2. Restraints
3.5.2.1. Dearth of skilled professionals
3.5.3. Opportunities
3.5.3.1. Increasing awareness about the advantages of amniotic membrane transplant
CHAPTER 4: AMNIOTIC MEMBRANE MARKET BY PRODUCT
4.1. Overview
4.2. Market Size and Forecast
4.3. Cryopreserved Amniotic Membrane
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast by region
4.4. Lyophilization Amniotic Membrane
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast by region
CHAPTER 5: AMNIOTIC MEMBRANE MARKET BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Surgical Wounds
5.2.1. Market size and forecast by region
5.3. Ophthalmology
5.3.1. Market size and forecast by region
5.4. Others
5.4.1. Market size and forecast by region
CHAPTER 6: AMNIOTIC MEMBRANE MARKET BY END-USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospitals
6.2.1. Market size and forecast by region
6.3. Ambulatory Surgical Centers
6.3.1. Market size and forecast by region
6.4. Specialized Clinics
6.4.1. Market size and forecast by region
6.5. Research Centers & Laboratory
6.5.1. Market size and forecast by region
CHAPTER 7: AMNIOTIC MEMBRANE MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast
7.2. North America
7.2.1. North America Market size and forecast by country
7.2.2. North America Market size and forecast by Product
7.2.3. North America Market size and forecast by Application
7.2.4. North America Market size and forecast by End User
7.2.1.1. U.S. Market size and forecast by product
7.2.1.2. U.S. Market size and forecast by application
7.2.1.3. U.S. Market size and forecast by end user
7.2.1.4. Canada Market size and forecast by product
7.2.1.5. Canada Market size and forecast by application
7.2.1.6. Canada Market size and forecast by end user
7.2.1.7. Mexico Market size and forecast by product
7.2.1.8. Mexico Market size and forecast by application
7.2.1.9. Mexico Market size and forecast by end user
7.3. Europe
7.3.1. Europe Market size and forecast by product
7.3.1. Europe Market size and forecast by application
7.3.1. Europe Market size and forecast by end user
7.4. Asia-Pacific
7.4.1. Asia-Pacific market size and forecast, by product
7.4.2. Asia-Pacific market size and forecast, by application
7.4.3. Asia-Pacific market size and forecast, by end user
7.5. LAMEA
7.5.1. LAMEA Market size and forecast by product
7.5.1. LAMEA Market size and forecast by application
7.5.1. LAMEA Market size and forecast by end user
CHAPTER 8: COMPANY PROFILES
8.1. Alliqua BioMedical Inc.
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Business performance
8.1.4. Key strategic moves and developments
8.2. Amnio Technology, LLC
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Key strategic moves and developments
8.3. Applied Biologics LLC
8.3.1. Company overview
8.3.2. Company snapshot
8.4. FzioMed Inc.
8.4.1. Company overview
8.4.2. Company snapshot
8.5. Human Regenerative Technologies, LLC
8.5.1. Company overview
8.5.2. Company snapshot
8.6. Integra Lifesciences Holdings Corporation (Derma Sciences Inc.)
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Business performance
8.6.5. Key strategic moves and developments
8.7. Katena Products, Inc. (IOP Ophthalmics)
8.7.1. Company overview
8.7.2. Company snapshot
8.8. MiMedx Group Inc.
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Business performance
8.9. Skye Biologics Inc.
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Key strategic moves and developments
8.10. Tissue-Tech Inc. (Amniox Medical Inc.)
8.10.1. Company overview
8.10.2. Company snapshot
More…
Check for discount @ https://www.kdmarketresearch.com/discount/3463
About Us:
KD Market Research is one of the best market research organization that provides B2B research on the growth opportunities of the industry which is the prime factor of the overall revenue of the organization. We identify the pain points which our client is facing around revenue methods and provide them with a comprehensive database which helps them to make intelligent decisions that could ensure growth to the organization.
Our Services include market intelligence, competitive intelligence, and customized research. These research reports help the organizations to make quick and powerful decisions that make out highest growth in revenue.
Contact us -
KD Market Research
150 State Street, Albany,
New York, USA 12207
Email id sales@kdmarketresearch.com
Request for sample@ https://www.kdmarketresearch.com/sample/3463
The global amniotic membrane market size was valued at USD 2.26 billion in 2017 and is estimated to register a CAGR of 12.6% during the forecast period. The amnion is the innermost layer of the placenta and is used for wound healing mainly due to its bacteriostatic and pain reduction properties. Rising awareness in the recent past has led to a surge in the number of transplants leading to increasing demand for these tissue-based products. It has also led to a rise in the number of donations thus, fueling market growth.
The major factors that drive the growth of the amniotic membrane market is the rise geriatric population coupled with the increase in amniotic membrane based transplantation globally. However, dearth of skilled professionals and high cost of the surgeries involving amniotic membrane restrain the growth of the global amniotic membrane market. Moreover, the increase in awareness regarding the potential benefits of amniotic membrane among the patients as well as the healthcare professionals offers lucrative opportunities that boost the market.
The global amniotic membrane market is segmented based on product, application, end user, and region. Based on product, the market is bifurcated into cryopreserved amniotic membrane and lyophilization amniotic membrane. Based on application, it is divided into surgical wounds, ophthalmology, and others. Based on end user, itis classified into hospitals, ambulatory surgical centers, specialized clinics, and research centers & laboratory
Amniotic membranes are used in two categories, as a surgical graft or as a biological bandage for the treatment and management of wounds. The product usage facilitates re-epithelization acting as a scaffold when used as a graft. Its anti-inflammatory and anti-scarring properties are especially vital in case of burn injuries reducing intensified inflammation and discomfort.
Based on application, the market is segmented into surgical wounds, ophthalmology, and others. These products are most often used in ophthalmic surgeries to initiate faster recovery while reducing inflammation. These membranes are also used in reconstructive surgeries to reduce scarring and promote healing. According to estimates from American Society of Plastic Surgeons, over 17.5 million surgical cosmetic procedures were performed in U.S. in 2017. These facts are indicative of the rising number of individuals undergoing surgery to enhance their aesthetic appeal.
Thus, high product demand in cosmetic surgeries is boosting the market growth. These products are also used in reconstructive procedures, which is also propelling their demand. Usage of amniotic membranes for burn injury treatments enables rapid wound healing and epithelialization. It is also proven to reduce pain and facilitate easy movement of the affected area. Since the usage of this method proves to be cheaper than xenografts and allografts, it is increasingly being used across the globe, which is accelerating the segment growth.
End Use Insights
On the basis of end use, the market is segmented into hospitals, Ambulatory Surgical Centers (ASCs), specialty clinics, and research and academic institutes. Hospitals are the primary care settings facilitating easy treatment for a wide range of diseases. These end use settings held the largest market share owing to frequent visits by patients and its ability to cater to a varied range of surgical interventions.
Rising use of amniotic membranes in ASCs is driving the segment growth. The use of these products is easy and effective and also facilitates wound recovery without frequent visits to hospitals or clinics. Thus, the ASC settings are also likely to witness rapid growth over the next few years.
Specialty clinics that are taken into consideration in the study are burn centers, plastic surgery clinics, dermatology clinics, and others. As most of these require methods to prevent infections and promote effective wound healing, the use of amniotic membranes is frequently seen in these settings facilitating market growth.
Research and academic institutes segment also holds a significant share in the amniotic membrane market owing to increasing R&D investments by major market players and hospitals to understand the possible product applications. The amniotic membrane provides a substrate for stem cells and can be used in various applications, propelling increasing research on the subject.
Enzyme Insights
Amniotic Membrane Market Share
The market constitutes a large number of global as well as local companies. These include Alliqua BioMedical, Inc.; Amnio Technology, LLC; Applied Biologics LLC; Human Regenerative Technologies, LLC; Derma Sciences; Katena Products, Inc.; MiMedx Group, Inc.; Skye Biologics, Inc.; Amniox Medical, Inc.; and Organogensis, Inc.
Majority of these companies have a well-established portfolio and have strong collaborations with tissue banks and hospitals to ensure placental donations. Almost all of the key market players are accredited by the American Association for Tissue Banks (AATB) to provide quality and sterile products. These factors thus are anticipated to aid in the growth of the market during the forecast period.
Companies are also involved in developing and marketing of membranes that are solely focused on specific areas of application. For instance, AmnioFix developed by MiMedx Group Inc. is a dehydrated product that is used particularly for surgical incisions, as it acts as a barrier membrane and reduces scar tissue formations.
Segments in this Report
By Product
Cryopreserved Amniotic Membrane
Lyophilization Amniotic Membrane
By Application
Surgical Wounds
Ophthalmology
Others
By End User
Hospitals Ambulatory Surgical Centers
Specialized Clinics
Research Centers & Laboratory
By Region
North America
U.S.
Canada
Mexico
Europe
Asia-Pacific
LAMEA
Browse full report with toc@ https://www.kdmarketresearch.com/report/amniotic-membrane-market-amr
Table of content
CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Benefits For Stakeholders
1.3. Key Market Segments
1.4. Research Methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market Definition And Scope
3.2. Key Findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.2.3. Top Winning Strategies, By Year, 2014-2017*
3.2.4. Top Winning Strategies, By Development, 2014-2017* (%)
3.2.5. Top Winning Strategies, By Company, 2014-2017*
3.3. Porters Five Forces Analysis
3.4. Top Player Positioning
3.5. Market Dynamics
3.5.1. Drivers
3.5.1.1. Growth in geriatric population
3.5.1.2. Increasing technological advancements and rising amniotic membrane transplantations
3.5.1.3. Increased awareness to reduce healthcare costs
3.5.2. Restraints
3.5.2.1. Dearth of skilled professionals
3.5.3. Opportunities
3.5.3.1. Increasing awareness about the advantages of amniotic membrane transplant
CHAPTER 4: AMNIOTIC MEMBRANE MARKET BY PRODUCT
4.1. Overview
4.2. Market Size and Forecast
4.3. Cryopreserved Amniotic Membrane
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast by region
4.4. Lyophilization Amniotic Membrane
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast by region
CHAPTER 5: AMNIOTIC MEMBRANE MARKET BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Surgical Wounds
5.2.1. Market size and forecast by region
5.3. Ophthalmology
5.3.1. Market size and forecast by region
5.4. Others
5.4.1. Market size and forecast by region
CHAPTER 6: AMNIOTIC MEMBRANE MARKET BY END-USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospitals
6.2.1. Market size and forecast by region
6.3. Ambulatory Surgical Centers
6.3.1. Market size and forecast by region
6.4. Specialized Clinics
6.4.1. Market size and forecast by region
6.5. Research Centers & Laboratory
6.5.1. Market size and forecast by region
CHAPTER 7: AMNIOTIC MEMBRANE MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast
7.2. North America
7.2.1. North America Market size and forecast by country
7.2.2. North America Market size and forecast by Product
7.2.3. North America Market size and forecast by Application
7.2.4. North America Market size and forecast by End User
7.2.1.1. U.S. Market size and forecast by product
7.2.1.2. U.S. Market size and forecast by application
7.2.1.3. U.S. Market size and forecast by end user
7.2.1.4. Canada Market size and forecast by product
7.2.1.5. Canada Market size and forecast by application
7.2.1.6. Canada Market size and forecast by end user
7.2.1.7. Mexico Market size and forecast by product
7.2.1.8. Mexico Market size and forecast by application
7.2.1.9. Mexico Market size and forecast by end user
7.3. Europe
7.3.1. Europe Market size and forecast by product
7.3.1. Europe Market size and forecast by application
7.3.1. Europe Market size and forecast by end user
7.4. Asia-Pacific
7.4.1. Asia-Pacific market size and forecast, by product
7.4.2. Asia-Pacific market size and forecast, by application
7.4.3. Asia-Pacific market size and forecast, by end user
7.5. LAMEA
7.5.1. LAMEA Market size and forecast by product
7.5.1. LAMEA Market size and forecast by application
7.5.1. LAMEA Market size and forecast by end user
CHAPTER 8: COMPANY PROFILES
8.1. Alliqua BioMedical Inc.
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Business performance
8.1.4. Key strategic moves and developments
8.2. Amnio Technology, LLC
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Key strategic moves and developments
8.3. Applied Biologics LLC
8.3.1. Company overview
8.3.2. Company snapshot
8.4. FzioMed Inc.
8.4.1. Company overview
8.4.2. Company snapshot
8.5. Human Regenerative Technologies, LLC
8.5.1. Company overview
8.5.2. Company snapshot
8.6. Integra Lifesciences Holdings Corporation (Derma Sciences Inc.)
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Business performance
8.6.5. Key strategic moves and developments
8.7. Katena Products, Inc. (IOP Ophthalmics)
8.7.1. Company overview
8.7.2. Company snapshot
8.8. MiMedx Group Inc.
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Business performance
8.9. Skye Biologics Inc.
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Key strategic moves and developments
8.10. Tissue-Tech Inc. (Amniox Medical Inc.)
8.10.1. Company overview
8.10.2. Company snapshot
More…
Check for discount @ https://www.kdmarketresearch.com/discount/3463
About Us:
KD Market Research is one of the best market research organization that provides B2B research on the growth opportunities of the industry which is the prime factor of the overall revenue of the organization. We identify the pain points which our client is facing around revenue methods and provide them with a comprehensive database which helps them to make intelligent decisions that could ensure growth to the organization.
Our Services include market intelligence, competitive intelligence, and customized research. These research reports help the organizations to make quick and powerful decisions that make out highest growth in revenue.
Contact us -
KD Market Research
150 State Street, Albany,
New York, USA 12207
Email id sales@kdmarketresearch.com
No comments:
Post a Comment